Literature DB >> 30362199

Assessment of ventral tegmental area-projecting GABAergic neurons from the bed nucleus of the stria terminalis in modulating binge-like ethanol intake.

Michel A Companion1, Todd E Thiele1,2.   

Abstract

Corticotropin-releasing factor (CRF) circuitry is a key component in plasticity underlying the transition to ethanol (EtOH) dependence. We have previously shown that chemogenetic silencing of CRF neurons stemming from the dorsolateral bed nucleus of the stria terminalis (dlBNST) and projecting to the ventral tegmental area (VTA) significantly blunts binge-like EtOH consumption. While CRF neurons in the BNST are thought to entail primarily a GABA phenotype, glutamatergic neurons within the BNST also innervate the VTA and influence consummatory behaviors. Here, we combined the well-validated Vgat-ires-Cre transgenic mice with chemogenetic tools to extend our previous findings and corroborate the contribution of the VTA-projecting dlBNST GABAergic circuitry in modulating binge-like EtOH consumption using "drinking-in-the-dark" procedures. Mice were given bilateral injection of Gi-coupled chemogenetic viral vector (or control virus) into the dlBNST and bilateral cannulae into the VTA. On test day, clozapine-N-oxide (CNO; or vehicle) was infused directly into the VTA to silence VTA-projecting dlBNST neurons and subsequent binge-like EtOH consumption was assessed. We then used immunohistochemistry (IHC) to determine the co-expression of CRF and viral vector. Our results showed that relative to vehicle treatment or CNO treatment in mice expressing the control virus, silencing VTA-projecting dlBNST GABAergic neurons by CNO treatment in mice expressing Gi-coupled chemogenetic virus significantly reduced binge-like EtOH intake. This effect was not seen with sucrose consumption. Our IHC results confirm a population of CRF-expressing GABAergic neurons within the dlBNST. This study directly establishes that VTA-projecting GABAergic neurons of the dlBNST modulate binge-like EtOH consumption.
© 2018 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  chemogenetics; corticotropin-releasing factor; drinking-in-the-dark; extended amygdala

Mesh:

Substances:

Year:  2018        PMID: 30362199      PMCID: PMC6312688          DOI: 10.1111/ejn.14222

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  23 in total

1.  Genetic cell targeting uncovers specific neuronal types and distinct subregions in the bed nucleus of the stria terminalis.

Authors:  Amanda Q Nguyen; Julie A D Dela Cruz; Yanjun Sun; Todd C Holmes; Xiangmin Xu
Journal:  J Comp Neurol       Date:  2016-01-26       Impact factor: 3.215

2.  Assessment of the Effects of 6 Standard Rodent Diets on Binge-Like and Voluntary Ethanol Consumption in Male C57BL/6J Mice.

Authors:  Simon Alex Marshall; Jennifer A Rinker; Langston K Harrison; Craig A Fletcher; Tina M Herfel; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2015-06-25       Impact factor: 3.455

3.  Leptin action on GABAergic neurons prevents obesity and reduces inhibitory tone to POMC neurons.

Authors:  Linh Vong; Chianping Ye; Zongfang Yang; Brian Choi; Streamson Chua; Bradford B Lowell
Journal:  Neuron       Date:  2011-07-14       Impact factor: 17.173

4.  Three types of neurochemical projection from the bed nucleus of the stria terminalis to the ventral tegmental area in adult mice.

Authors:  Takehiro Kudo; Motokazu Uchigashima; Taisuke Miyazaki; Kohtarou Konno; Miwako Yamasaki; Yuchio Yanagawa; Masabumi Minami; Masahiko Watanabe
Journal:  J Neurosci       Date:  2012-12-12       Impact factor: 6.167

Review 5.  Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism.

Authors:  Emily G Lowery; Todd E Thiele
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-03       Impact factor: 4.388

6.  "Drinking in the Dark" (DID): a simple mouse model of binge-like alcohol intake.

Authors:  Todd E Thiele; John C Crabbe; Stephen L Boehm
Journal:  Curr Protoc Neurosci       Date:  2014-07-01

7.  GABAA receptors in the posterior, but not anterior, ventral tegmental area mediate Ro15-4513-induced attenuation of binge-like ethanol consumption in C57BL/6J female mice.

Authors:  Laverne C Melón; Stephen L Boehm
Journal:  Behav Brain Res       Date:  2011-02-12       Impact factor: 3.332

8.  Evaluation of a simple model of ethanol drinking to intoxication in C57BL/6J mice.

Authors:  Justin S Rhodes; Karyn Best; John K Belknap; Deborah A Finn; John C Crabbe
Journal:  Physiol Behav       Date:  2005-01-31

9.  Central CRF neurons are not created equal: phenotypic differences in CRF-containing neurons of the rat paraventricular hypothalamus and the bed nucleus of the stria terminalis.

Authors:  Joanna Dabrowska; Rimi Hazra; Ji-Dong Guo; Sarah Dewitt; Donald G Rainnie
Journal:  Front Neurosci       Date:  2013-08-30       Impact factor: 4.677

10.  Administration of antenatal glucocorticoids and postnatal surfactant ameliorates respiratory distress syndrome-associated neonatal lethality in Erk3(-/-) mouse pups.

Authors:  Milenka Cuevas Guaman; Elena Sbrana; Cynthia Shope; Lori Showalter; Min Hu; Sylvain Meloche; Kjersti Aagaard
Journal:  Pediatr Res       Date:  2014-04-14       Impact factor: 3.756

View more
  9 in total

1.  α2A-adrenergic heteroreceptors are required for stress-induced reinstatement of cocaine conditioned place preference.

Authors:  Rafael E Perez; Aakash Basu; Bretton P Nabit; Nicholas A Harris; Oakleigh M Folkes; Sachin Patel; Ralf Gilsbach; Lutz Hein; Danny G Winder
Journal:  Neuropsychopharmacology       Date:  2020-02-19       Impact factor: 7.853

Review 2.  Driving the Downward Spiral: Alcohol-Induced Dysregulation of Extended Amygdala Circuits and Negative Affect.

Authors:  Samuel W Centanni; Gaurav Bedse; Sachin Patel; Danny G Winder
Journal:  Alcohol Clin Exp Res       Date:  2019-08-30       Impact factor: 3.455

Review 3.  Reciprocal midbrain-extended amygdala circuit activity in preclinical models of alcohol use and misuse.

Authors:  Elizabeth M Avegno; Nicholas W Gilpin
Journal:  Neuropharmacology       Date:  2021-10-25       Impact factor: 5.250

Review 4.  Corticotropin releasing factor and norepinephrine related circuitry changes in the bed nucleus of the stria terminalis in stress and alcohol and substance use disorders.

Authors:  Angela E Snyder; Yuval Silberman
Journal:  Neuropharmacology       Date:  2021-10-06       Impact factor: 5.250

5.  Pathway-specific inhibition of critical projections from the mediodorsal thalamus to the frontal cortex controls kindled seizures.

Authors:  Evan Wicker; Safwan K Hyder; Patrick A Forcelli
Journal:  Prog Neurobiol       Date:  2022-05-12       Impact factor: 10.885

Review 6.  Circuit selectivity in drug versus natural reward seeking behaviors.

Authors:  Rusty W Nall; Jasper A Heinsbroek; Todd B Nentwig; Peter W Kalivas; Ana-Clara Bobadilla
Journal:  J Neurochem       Date:  2021-02-13       Impact factor: 5.546

7.  Dissociable mesolimbic dopamine circuits control responding triggered by alcohol-predictive discrete cues and contexts.

Authors:  Milan D Valyear; Iulia Glovaci; Audrey Zaari; Soraya Lahlou; Ivan Trujillo-Pisanty; C Andrew Chapman; Nadia Chaudhri
Journal:  Nat Commun       Date:  2020-07-28       Impact factor: 14.919

8.  Extended Amygdala Neuropeptide Circuitry of Emotional Arousal: Waking Up on the Wrong Side of the Bed Nuclei of Stria Terminalis.

Authors:  William J Giardino; Matthew B Pomrenze
Journal:  Front Behav Neurosci       Date:  2021-02-09       Impact factor: 3.558

9.  Distinct and Overlapping Patterns of Acute Ethanol-Induced C-Fos Activation in Two Inbred Replicate Lines of Mice Selected for Drinking to High Blood Ethanol Concentrations.

Authors:  Stacey L Robinson; Ana Paula S Dornellas; Nathan W Burnham; Christa A Houck; Kendall L Luhn; Sophie C Bendrath; Michel A Companion; Honoreé W Brewton; Rhiannon D Thomas; Montserrat Navarro; Todd E Thiele
Journal:  Brain Sci       Date:  2020-12-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.